
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Aclaris Therapeutics, Inc. operates in the Biotechnology Research industry and is headquartered in United States.
Aclaris Therapeutics, Inc. has approximately 51-200 employees employees.
Aclaris Therapeutics, Inc. is based in Wayne, Pennsylvania, United States.
Yes. Aclaris Therapeutics, Inc. is a publicly traded company.
You can reach Aclaris Therapeutics, Inc.’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.
Our team will be in touch soon. If you have any questions, please email us at info@scalelist.com
Just a few more details..
Our team will be in touch soon. If you have any questions, please email us at arnaud@scalelist.com